Literature DB >> 25688920

Inactivation of myeloperoxidase by benzoic acid hydrazide.

Jiansheng Huang1, Forrest Smith1, Jennifer R Panizzi2, Douglas C Goodwin3, Peter Panizzi4.   

Abstract

Myeloperoxidase (MPO) is expressed by myeloid cells for the purpose of catalyzing the formation of hypochlorous acid, from chloride ions and reaction with a hydrogen peroxide-charged heme covalently bound to the enzyme. Most peroxidase enzymes both plant and mammalian are inhibited by benzoic acid hydrazide (BAH)-containing compounds, but the mechanism underlying MPO inhibition by BAH compounds is largely unknown. Recently, we reported MPO inhibition by BAH and 4-(trifluoromethyl)-BAH was due to hydrolysis of the ester bond between MPO heavy chain glutamate 242 ((HC)Glu(242)) residue and the heme pyrrole A ring, freeing the heme linked light chain MPO subunit from the larger remaining heavy chain portion. Here we probed the structure and function relationship behind this ester bond cleavage using a panel of BAH analogs to gain insight into the constraints imposed by the MPO active site and channel leading to the buried protoporphyrin IX ring. In addition, we show evidence that destruction of the heme ring does not occur by tracking the heme prosthetic group and provide evidence that the mechanism of hydrolysis follows a potential attack of the (HC)Glu(242) carbonyl leading to a rearrangement causing the release of the vinyl-sulfonium linkage between (HC)Met(243) and the pyrrole A ring.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Benzoic acid hydrazide; Inflammation; Myeloperoxidase

Mesh:

Substances:

Year:  2015        PMID: 25688920      PMCID: PMC4779370          DOI: 10.1016/j.abb.2015.01.028

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  27 in total

1.  The 2.0 A crystal structure of catalase-peroxidase from Haloarcula marismortui.

Authors:  Yusuke Yamada; Taketomo Fujiwara; Takao Sato; Noriyuki Igarashi; Nobuo Tanaka
Journal:  Nat Struct Biol       Date:  2002-09

Review 2.  Autocatalytic radical reactions in physiological prosthetic heme modification.

Authors:  Christophe Colas; Paul R Ortiz de Montellano
Journal:  Chem Rev       Date:  2003-06       Impact factor: 60.622

3.  Asp-225 and glu-375 in autocatalytic attachment of the prosthetic heme group of lactoperoxidase.

Authors:  Christophe Colas; Jane M Kuo; Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2001-12-26       Impact factor: 5.157

4.  Compound I of myeloperoxidase.

Authors:  J E Harrison; T Araiso; M M Palcic; H B Dunford
Journal:  Biochem Biophys Res Commun       Date:  1980-05-14       Impact factor: 3.575

5.  Quantitative determination of myeloperoxidase using tetramethylbenzidine as substrate.

Authors:  P C Andrews; N I Krinsky
Journal:  Anal Biochem       Date:  1982-12       Impact factor: 3.365

6.  Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide.

Authors:  A J Kettle; C A Gedye; C C Winterbourn
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

7.  A kinetic analysis of the interaction of human myeloperoxidase with hydrogen peroxide, chloride ions, and protons.

Authors:  P C Andrews; N I Krinsky
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

8.  Protein control of prosthetic heme reactivity. Reaction of substrates with the heme edge of horseradish peroxidase.

Authors:  M A Ator; P R Ortiz de Montellano
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

9.  Structure and catalytic mechanism of horseradish peroxidase. Regiospecific meso alkylation of the prosthetic heme group by alkylhydrazines.

Authors:  M A Ator; S K David; P R Ortiz de Montellano
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

10.  Horseradish peroxidase mutants that autocatalytically modify their prosthetic heme group: insights into mammalian peroxidase heme-protein covalent bonds.

Authors:  Christophe Colas; Paul R Ortiz De Montellano
Journal:  J Biol Chem       Date:  2004-03-23       Impact factor: 5.157

View more
  7 in total

1.  Luminol Chemiluminescence Reports Photodynamic Therapy-Generated Neutrophil Activity In Vivo and Serves as a Biomarker of Therapeutic Efficacy.

Authors:  Richard W Davis; Emma Snyder; Joann Miller; Shirron Carter; Cassandra Houser; Astero Klampatsa; Steven M Albelda; Keith A Cengel; Theresa M Busch
Journal:  Photochem Photobiol       Date:  2018-11-26       Impact factor: 3.421

2.  Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin.

Authors:  Pamela S Hair; Kenji M Cunnion; Neel K Krishna
Journal:  Int J Pept       Date:  2017-09-10

Review 3.  Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19.

Authors:  Jiansheng Huang; Wenliang Song; Hui Huang; Quancai Sun
Journal:  J Clin Med       Date:  2020-04-15       Impact factor: 4.241

4.  Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.

Authors:  Jiansheng Huang; Patricia G Yancey; Huan Tao; Mark S Borja; Loren E Smith; Valentina Kon; Sean S Davies; MacRae F Linton
Journal:  Nutrients       Date:  2020-06-30       Impact factor: 5.717

Review 5.  Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives.

Authors:  Amjad A Khan; Mohammed A Alsahli; Arshad H Rahmani
Journal:  Med Sci (Basel)       Date:  2018-04-18

6.  Myeloperoxidase Inhibitory and Antioxidant Activities of (E)-2-Hydroxy-α-aminocinnamic Acids Obtained through Microwave-Assisted Synthesis.

Authors:  Astrid Rivera-Antonio; Martha Cecilia Rosales-Hernández; Irving Balbuena-Rebolledo; José Martín Santiago-Quintana; Jessica Elena Mendieta-Wejebe; José Correa-Basurto; Juan Benjamín García-Vázquez; Efrén Venancio García-Báez; Itzia I Padilla-Martínez
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

Review 7.  Roles of Reconstituted High-Density Lipoprotein Nanoparticles in Cardiovascular Disease: A New Paradigm for Drug Discovery.

Authors:  Jiansheng Huang; Dongdong Wang; Li-Hao Huang; Hui Huang
Journal:  Int J Mol Sci       Date:  2020-01-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.